G1 Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €71.09M +60.8% -€41.33M -67.5% -58.1% +2.3 pp -€33.03M -70.1% -46.5% +2.0 pp
    €44.20M +63.0% -€127.13M -0.5% -287.6% +1.8 pp -€110.38M -3.0% -249.7% +1.7 pp
    €27.12M -30.5% -€127.81M +49.5% -471.3% -2.5 pp -€113.82M +57.8% -419.7% -2.3 pp
    €39.02M +∞% -€85.51M -18.7% -219.2% -2.2 pp -€72.15M -13.5% -184.9% -1.8 pp
    €0.00 +NaN% -€105.19M +43.2% N/A -€83.45M +31.6% N/A
    €0.00 +NaN% -€73.48M +41.9% N/A -€63.41M +46.5% N/A
    €0.00 +NaN% -€51.80M +98.5% N/A -€43.27M +101.8% N/A
    €0.00 -100.0% -€26.10M +49.5% N/A -€21.44M +80.9% N/A
    €449.73K -49.9% -€17.46M +182.2% -3,881.8% -32 pp -€11.85M +115.1% -2,635.6% -20 pp
    €898.34K -€6.19M -688.6% -€5.51M -613.3%

    Notifications